LITTLE ROCK, Ark., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Westrock Coffee Company (NASDAQ: WEST) ("Westrock Coffee" or the “Company") today announced that it will report its third quarter 2025 results on Thursday, November 6, 2025 after market close. The announcement will be followed by a live earnings conference call at 4:30 p.m. ET. To participate in the live earnings call and question and answer session, please register HERE and dial-in information will be provided directly to you. The live audio webcast will ...

Core Insights - Rumble has launched a subscription bundle that combines Rumble Premium and Perplexity Pro, enhancing user experience through AI-powered tools [1][3] - The subscription bundle is offered at a promotional price of $19.99 per month, down from a combined value of $29.99 per month, available until December 31, 2025 [2] Company Overview - Rumble is a high-growth video-sharing platform and cloud services provider, founded in 2013, aiming to create an independent infrastructure resistant to censorship by major tech companies [4] - Perplexity, founded in 2022, is an AI-powered answer engine that provides accurate answers and deep research from credible sources, answering over 150 million questions globally each week [4]

Core Viewpoint - Bitfarms Ltd. plans to offer US$300 million in convertible senior notes due 2031, with an option for initial purchasers to buy an additional US$60 million, subject to market conditions and Toronto Stock Exchange approval [1][10]. Summary by Sections Description of Notes - The convertible notes will be senior unsecured obligations, accruing interest semi-annually starting July 15, 2026, and maturing on January 15, 2031. They will be convertible under specific conditions before October 15, 2030, and at the holder's option thereafter [2][3]. Use of Proceeds - Net proceeds from the offering will be used for general corporate purposes and to cover costs associated with capped call transactions [4]. Capped Call Transactions - Bitfarms plans to enter into cash-settled capped call transactions to mitigate potential economic dilution from the convertible notes. These transactions will cover the number of common shares underlying the notes, with a cap targeted at a 125% premium to the last reported sale price of Bitfarms' common shares [5][6]. Market Impact - The capped call counterparties may engage in purchasing common shares or entering derivative transactions, which could influence the market price of the common shares and convertible notes [8]. Regulatory Compliance - The convertible notes and the common shares will not be registered under the U.S. Securities Act and will be offered only to qualified institutional buyers. Offers in Canada will be made under exemptions from prospectus requirements [9][10]. Company Overview - Bitfarms is a North American energy and digital infrastructure company focused on building and operating data centers for high-performance computing and Bitcoin mining, with a significant portion of its energy pipeline based in the U.S. [12][13].

HARRISBURG, Pa., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Orrstown Financial Services, Inc. (NASDAQ: ORRF), the holding company of Orrstown Bank, announced today that it will report third quarter 2025 earnings at the close of business on Tuesday, October 21, 2025. Management will host a conference call and webcast to review the Company’s quarterly results on Wednesday, October 22, 2025, at 9:00 am ET. The conference call and webcast details are below: Earnings Release: Tuesday, October 21, 2025, After Market Close ...

Core Insights - LegalZoom.com, Inc. will report its financial results for the third quarter ended September 30, 2025, on November 5, 2025, after market close [1] - A conference call and webcast will be hosted by CEO Jeff Stibel and COO/CFO Noel Watson at 4:30 p.m. ET on the same day to discuss the financial results [2] Company Overview - LegalZoom is a leading online platform for legal services, providing tools and guidance for individuals and small businesses to navigate the legal system [4] - The company combines technology with access to experienced attorneys, offering services such as business formations, compliance, estate planning, and ongoing legal support [4] - With over two decades of experience, LegalZoom has served millions of customers, enhancing confidence in managing legal needs [5]

Core Viewpoint - Mister Car Wash, Inc. will release its financial results for Q3 2025 on October 29, 2025, followed by a conference call to discuss these results [1]. Group 1: Financial Results Announcement - The financial results for the third quarter of 2025 will be released after market close on October 29, 2025 [1]. - A conference call to discuss the financial results will take place at 4:30 p.m. Eastern Time on the same day [1]. Group 2: Conference Call Participation - Investors and analysts can participate in the call by dialing 855-209-8213 or 1-412-542-4146 for international callers [2]. - A live audio webcast of the conference call will be available online [2]. - A recorded replay of the conference call will be accessible approximately three hours after its conclusion [2]. Group 3: Company Overview - Mister Car Wash, Inc. is headquartered in Tucson, Arizona, and operates approximately 525 locations [3]. - The company has the largest car wash subscription program in North America [3]. - Mister Car Wash is committed to providing exceptional customer experiences and responsible environmental practices [3].

REDWOOD CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the third quarter of 2025 after the close of trading on Wednesday, October 29, 2025. Thereafter, company management will host a conference call to discuss the results beginning at 1:30 p.m. PT / 4:30 p.m. ET. Parties interested in participating by phone should regi ...

Core Viewpoint - Appian is set to release its financial results for Q3 2025 on November 6, 2025, before the U.S. markets open, and will host a conference call to discuss these results and the business outlook [1]. Group 1: Financial Results Announcement - The financial results for the third quarter ended September 30, 2025, will be announced before the U.S. financial markets open on November 6, 2025 [1]. - A conference call will be held at 8:30 a.m. Eastern Time to review the financial results and business outlook [2]. Group 2: Conference Call Details - Participants can access the conference call via a registration link and will need a phone with a dial-in and PIN [2]. - The conference call will also be available live via webcast on the Investor Relations page of Appian's website [2]. - A replay of the conference call will be accessible on the Investor Relations page after the live event [2]. Group 3: Company Overview - Appian is recognized as The Process Company, providing a software platform that enhances organizational processes, reduces costs, improves customer experiences, and offers a strategic advantage [3]. - The company serves many of the world's largest companies across various industries, emphasizing its commitment to client success [3].

Core Insights - Adaptive Biotechnologies Corporation will report its financial results for Q3 2025 on November 5, 2025, after market close [1] - A conference call will follow the financial results announcement, starting at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time [1] Company Overview - Adaptive Biotechnologies is a commercial-stage biotechnology company focused on utilizing the adaptive immune system's biology to develop clinical products for disease diagnosis and treatment [3] - The company aims to decode the adaptive immune system to enhance its diagnostic and therapeutic capabilities, which have been underutilized due to previous decoding challenges [3] - The proprietary immune medicine platform of the company allows for the translation of the adaptive immune system's genetics with scale, precision, and speed [3] - The company operates in two business segments: Minimal Residual Disease (MRD) and Immune Medicine, providing products and clinical pipelines for diseases like cancer and autoimmune disorders [3] - The goal is to create and commercialize immune-driven clinical products tailored to individual patients [3]

SAN JOSE, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the third quarter of 2025 after market close on Tuesday, November 4, 2025. The Company’s management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in listening to the conferenc ...